REVOLADE added to standard IST resulted in improved
response rates for treatment-naive patients 1
REVOLADE was initiated at Day 1 and responses were measured at 6 months1
CsA, cyclosporine; h-ATG, horse antithymocyte globulin; SAA, severe aplastic anemia.
*Standard IST=horse antithymocyte globulin and cyclosporine.
† Historical cohort consisted of patients who received h-ATG/CsA while on randomized control arms of the 2 most recent clinical trials at the NIH.